Marketing Automation Leader Marketo Named a CRN Emerging Technology Vendor
The Marketo Alliance Helps Marketo Align Marketing and Sales to Achieve Rapid Customer Growth
US Federal IT Trends 2010-2015
Market Research Media Ltd announces a series of market research reports covering US Federal IT trends for period 2010-2015.
Automotive Battery Industry Growing, Germany a Key Driver
The automotive battery industry is growing
at a rapid rate despite the economic crisis. The increased focus on hybrid
and electric vehicles has led to battery innovation and market growth. With
heavy investment in research and development, Germany is positioned to be a
global leader in this market segment. Business opportunities in Germany
resulting from this trend will be presented at the Advanced Automotive
Battery & EC Capacitor Conference in Long Beach, California from June 8-12.
Saepio Technologies' Success Model Delivers Quick ROI and Fast Implementation for Companies Deploying Marketing Asset Management Technology
Saepio Technologies is helping corporations and organizations with a rapid implementation and fast return on investment (ROI) of Marketing Asset Management Technology.
Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
Siemens Corporate Research (SCR), Inc. (www.usa.siemens.com/research) announced that it developed the RAPID2 system to speed the biomarker discovery process for the development of rapid diagnostic tests. This system marries the power of information technology with today's improved genomic sequencing to quickly identify genomic signatures unique to the set of organisms to be detected. These signatures are the foundation for a new generation of molecular diagnostic tests for the rapid detection of healthcare-associated infections such as the potentially deadly Methicillin-Resistant Staphylococcus Aureus (MRSA).
Sanofi-Aventis' and Roche/Chugai's Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Sanofi-Aventis' Eloxatin, Indian brand/generics (oxaliplatin) and Roche/Chugai's Xeloda, Indian brand/generics (capecitabine) will dominate the Indian colorectal cancer drug market through 2013. However, as a result of the increased use of targeted agents and rapid growth of the Indian colorectal cancer drug market the combined market share of these two drugs will fall from 67 percent in 2008 to 52 percent in 2013.
The Appeal of Far Infrared LuxSauna Surges Despite Sluggish Economy
Multiple health benefits and low costs of far infrared saunas are behind the rapid growth of LuxSauna as they launch into multiple markets.
Related Searches
